5.46 - 5.56
4.95 - 8.28
1.3K / 2.4K (Avg.)
-277.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.47%
Revenue growth under 50% of STERV.HE's 5.51%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-13.70%
Negative gross profit growth while STERV.HE is at 33.69%. Joel Greenblatt would examine cost competitiveness or demand decline.
-8.65%
Negative EBIT growth while STERV.HE is at 117.36%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-8.65%
Negative operating income growth while STERV.HE is at 117.36%. Joel Greenblatt would press for urgent turnaround measures.
-12.90%
Negative net income growth while STERV.HE stands at 104.65%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-13.64%
Negative EPS growth while STERV.HE is at 105.26%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-13.64%
Negative diluted EPS growth while STERV.HE is at 102.63%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
0.86%
Slight or no buyback while STERV.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
102.71%
OCF growth above 1.5x STERV.HE's 22.10%. David Dodd would confirm a clear edge in underlying cash generation.
54.81%
FCF growth above 1.5x STERV.HE's 14.29%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-7.66%
Negative 10Y revenue/share CAGR while STERV.HE stands at 5.71%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
28.63%
5Y revenue/share CAGR above 1.5x STERV.HE's 11.53%. David Dodd would look for consistent product or market expansions fueling outperformance.
14.18%
3Y revenue/share CAGR above 1.5x STERV.HE's 2.30%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
759.93%
10Y OCF/share CAGR above 1.5x STERV.HE's 140.88%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
130.01%
5Y OCF/share CAGR above 1.5x STERV.HE's 28.55%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
297.47%
3Y OCF/share CAGR above 1.5x STERV.HE's 96.35%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
130.76%
Below 50% of STERV.HE's 550.71%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
191.88%
Below 50% of STERV.HE's 576.97%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
38.43%
Below 50% of STERV.HE's 102.65%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
116.64%
10Y equity/share CAGR 1.25-1.5x STERV.HE's 89.66%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
68.95%
5Y equity/share CAGR at 75-90% of STERV.HE's 84.01%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
29.57%
3Y equity/share CAGR at 50-75% of STERV.HE's 59.13%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.29%
Firm’s AR is declining while STERV.HE shows 4.52%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
2.86%
We show growth while STERV.HE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
5.47%
Asset growth at 75-90% of STERV.HE's 6.16%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
3.51%
Under 50% of STERV.HE's 9.35%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-1.00%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
36.92%
We expand SG&A while STERV.HE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.